First Header Logo Second Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Feldman, Steven
One or more keywords matched the following items that are connected to Feldman, Steven
Item TypeName
Academic Article A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis.
Academic Article Tacrolimus ointment is effective for facial and intertriginous psoriasis.
Academic Article Etanercept improves the health-related quality of life of patients with psoriasis: results of a phase III randomized clinical trial.
Academic Article Gel vehicles are not inherently more irritating than creams.
Academic Article Topical tacrolimus 0.1% improves symptoms of hand dermatitis in patients treated with a prednisone taper.
Academic Article Efficacy and safety of calcipotriene 0.005% foam for the treatment of plaque-type psoriasis: results of two multicenter, randomized, double-blind, vehicle-controlled, phase III clinical trials.
Academic Article A multicenter, randomized, double-blind study of the efficacy and safety of calcipotriene foam, 0.005%, vs vehicle foam in the treatment of plaque-type psoriasis of the scalp.
Academic Article The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis.
Academic Article Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial.
Academic Article Induction of withdrawal-like symptoms in a small randomized, controlled trial of opioid blockade in frequent tanners.
Academic Article Plasma beta-endorphin levels in frequent and infrequent tanners before and after ultraviolet and non-ultraviolet stimuli.
Academic Article Clobetasol propionate for psoriasis: are ointments really more potent?
Academic Article A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis.
Academic Article Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial.
Concept Double-Blind Method
Academic Article The efficacy and tolerability of tazarotene foam, 0.1%, in the treatment of acne vulgaris in 2 multicenter, randomized, vehicle-controlled, double-blind studies.
Academic Article A double-blind, randomized clinical trial of 20% alpha/poly hydroxy acid cream to reduce scaling of lesions associated with moderate, chronic plaque psoriasis.
Academic Article Predicting improvement in signs and symptoms of plaque psoriasis after 1 week of treatment with clobetasol propionate 0.05% spray.
Academic Article Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial.
Academic Article Topical 0.25% desoximetasone spray efficacy for moderate to severe plaque psoriasis: a randomized clinical trial.
Academic Article Topical Desoximetasone 0.25% Spray and Its Vehicle Have Little Potential for Irritation or Sensitization.
Academic Article A Randomized, Double-Blind, Placebo-Controlled Study of the Vasoconstrictor Potency of Topical 0.25% Desoximetasone Spray: A High to Super High Range of Potency (Class I to Class II) Corticosteroid Formulation.
Academic Article 4-Day evaluation of the irritation potential of topical desoximetasone 0.25% and 0.05% spray on light-exposed skin.
Academic Article Secukinumab improves scalp pain, itching, scaling and quality of life in patients with moderate-to-severe scalp psoriasis.
Academic Article Evaluating crisaborole as a treatment option for atopic dermatitis.
Search Criteria
  • Double Blind Method